Comment from SeQure

AnonymousSupportBusiness
Summary: SeQure, a contract research organization, supports the draft guidance and suggests specific improvements regarding minimum sensitivity for off-target confirmation, the inclusion of optical genome mapping for structural variations, and the recommendation of insertion site analysis for certain payloads. They also advocate for high-throughput biochemical assays to account for human genetic variation and editor-specific nomination strategies.
See attached file(s)

View on Regulations.gov